TITLE

Burden of disease due to cancer in England and Wales

AUTHOR(S)
Jayatilleke, N.; Pashayan, N.; Powles, J.W.
PUB. DATE
June 2012
SOURCE
Journal of Public Health;Jun2012, Vol. 34 Issue 2, p287
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background This study aims to estimate the burden of cancer in England and Wales using disability-adjusted life years (DALYs) and to determine if the ranking of relative importance changes with metric used. Methods DALYs are the sum of years of life lost due to mortality and years lost due to disability. Annual DALYs due to cancer were calculated using cancer registration, mortality, disability weights and World Health Organization methodology. Results There were 8 605 362 DALYs due to cancer (3242 DALYs/100 000 population/year). Of the total, 47% corresponded to lung, prostate and colorectal cancers in males and 56% to breast, lung, colorectal and ovarian cancers in females. Mortality (86% of DALYs) contributed predominantly to DALYs. Individuals of 65–75 years contributed to 28% of DALYs. Among females, lung cancer ranked highest by death rates, whereas the highest DALYs were from breast cancer. Conclusions Highest DALYs were due to lung, breast, prostate and colorectal cancers in England and Wales. The addition of the disability component changes the relative position of some of the top cancers. Although metrics based on deaths alone capture most effects of cancer on population health levels, important additional perspectives, relevant to the planning of services, can be gained from burden of disease analyses.
ACCESSION #
75696356

 

Related Articles

  • The 2008 Global Burden of Disease study in Brazil: a new methodological approach for estimation of injury morbidity. von-Doellinger, Vanessa; Campos, Mônica; Mendes, Luiz; Schramm, Joyce // Revista Panamericana de Salud Publica;dic2014, Vol. 36 Issue 6, p368 

    Objective . To present the methodological approach used to estimate injury morbidity (Years Lived with Disability, YLD) in the 2008 Global Burden of Disease study in Brazil (GBD-Br). Methods. YLD was based on the admission rate for injuries from both public and private sector facilities....

  • Low-Risk Lifestyle Behaviors and All-Cause Mortality: Findings From the National Health and Nutrition Examination Survey III Mortality Study. Ford, Earl S.; Zhao, Guixiang; Tsai, James; Li, Chaoyang // American Journal of Public Health;Oct2011, Vol. 101 Issue 10, p1922 

    Objectives. We examined the relationship between 4 low-risk behaviors-never smoked, healthy diet, adequate physical activity, and moderate alcohol consumption- and mortality in a representative sample of people in the United States. Methods. We used data from 16958 participants aged 17 years and...

  • TRENDS IN AGE-ADJUSTED CORONARY HEART DISEASE MORTALITY RATES IN SLOVAKIA BETWEEN 1993 AND 2009. Psota, Marek; Pekarčikoá, Jarmila; O'Mullane, Monica; Rusnák, Martin // Central European Journal of Public Health;Jun2013, Vol. 21 Issue 2, p72 

    Cardiovascular diseases (CVD) and especially coronary heart disease (CHD) are the main causes of death in the Slovak Republic (SR). The aim of this study is to explore trends in age-adjusted coronary heart disease mortality rates in the whole Slovak population and in the population of working...

  • MORBIDITY AND MORTALITY DUE TO AIDS: A STUDY OF BURDEN OF DISEASE AT A MUNICIPAL LEVEL. DA SILVA, Jane; RAMOS, Victoria; DA SILVA, Helena Caetano Gonçalves; TRAEBERT, Jefferson // Revista do Instituto de Medicina Tropical de Sao Paulo;Sep/Oct2015, Vol. 57 Issue 5, p407 

    Introduction: The purpose of measuring the burden of disease involves aggregating morbidity and mortality components into a single indicator, the disability-adjusted life year (DALY), to measure how much and how people live and suffer the impact of a disease. Objective: To estimate the global...

  • Personal and Societal Health Quality Lost to Tuberculosis. Miller, Thaddeus L.; McNabb, Scott J. N.; Hilsenrath, Peter; Pasipanodya, Jotam; Weis, Stephen E. // PLoS ONE;2009, Vol. 4 Issue 4, p1 

    Background: In developed countries, tuberculosis is considered a disease with little loss of Quality-Adjusted Life Years (QALYs). Tuberculosis treatment is predominantly ambulatory and death from tuberculosis is rare. Research has shown that there are chronic pulmonary sequelae in a majority of...

  • Calculating disability-adjusted-life-years lost (DALYs) in discrete-time. Larson, Bruce A. // Cost Effectiveness & Resource Allocation;2013, Vol. 11 Issue 1, p18 

    Disability-adjusted-life-years lost (DALYs) is a common outcome metric for cost-effectiveness analyses, and the equations used for such calculations have been presented previously by Fox-Rushby and Hanson (see, e.g., "Health Policy and Planning 16:326-331, 2001"). While the equations are clear,...

  • Burden of Cancers in Iran from 1990 to 2010: Findings from the Global Burden of Disease Study 2010. Modirian, Mitra; Rahimzadeh, Shadi; Cheraghi, Zahra; Moghaddam, Sahar Saeedi; Rezaei, Nazila; Tolide-ie, Hamid Reza; Kasaeian, Amir; Jamshidi, Hamid Reza; Ghobadi, Roya; Kompani, Farzad // Archives of Iranian Medicine (AIM);Oct2015, Vol. 18 Issue 10, p629 

    Background: Cancer is one of the most common non-communicable diseases in both sexes and a major cause of disability and death around the world, as well as in Iran. The aim of the present manuscript is to report the results of the Global Burden of Disease study 2010 (the GBD 2010) to compare...

  • Measuring the Population Impact of Introducing Stereotactic Ablative Radiotherapy for Stage I Non-Small Cell Lung Cancer in Canada. Louie, Alexander V.; Rodrigues, George B.; Palma, David A.; Senan, Suresh // Oncologist;Aug2014, Vol. 19 Issue 8, preceding p880 

    Background. The Cancer Risk Management Model (CRMM) was used to estimate the health and economic impact of introducing stereotactic ablative radiotherapy (SABR) for stage I non-small cell lung cancer (NSCLC) in Canada. Methods. The CRMM uses Monte Carlo microsimulation representative of all...

  • Cost Effectiveness of New Oral Anticoagulants for Stroke Prevention in Patients with Atrial Fibrillation in Two Different European Healthcare Settings. Verhoef, Talitha; Redekop, William; Hasrat, Fazila; Boer, Anthonius; Maitland-van der Zee, Anke // American Journal of Cardiovascular Drugs;Dec2014, Vol. 14 Issue 6, p451 

    Objectives: Our objectives were to investigate the cost effectiveness of apixaban, rivaroxaban, and dabigatran compared with coumarin derivatives for stroke prevention in patients with atrial fibrillation in a country with specialized anticoagulation clinics (the Netherlands) and in a country...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics